Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: PDT

Up to JPY3 Mil. Available for "Take on Challenges Beyond Common Sense!"; KADOKAWA ASCII Inviting Applications for "INNO-vation Program 2020"


TOKYO, July 10, 2020 /CNW/ -- KADOKAWA ASCII Research Laboratories, Inc. of Tokyo, the executing agency for the "INNO-vation Program," implemented by the Japanese Ministry of Internal Affairs and Communications, is soliciting applications for the program until August 31, 2020.

(Logo: https://kyodonewsprwire.jp/prwfile/release/M101933/202007071771/_prw_PI2fl_y3ty8BB3.jpg)

(Image: https://kyodonewsprwire.jp/prwfile/release/M101933/202007071771/_prw_PI1fl_R7OU5Ej4.jpg)

The COVID-19 pandemic's impact on society has been so extreme that there is no choice but to alter lifestyles down to the way people move about during the day. To overcome and eliminate this status quo and work toward changing their lives into a new and evolved normal, people must not forget about the extraordinary individuals who continue to face these challenges in the most difficult of circumstances and support their unique abilities that go beyond common sense. This program is for outside-the-box challengers in the ICT field. The "Disruptive Challenge" seeks to create disruptive value with a maximum challenge period of one year and total financial support of up to JPY3 million. The "Generation Award" looks to find small yet unique ideas and technology that look to build a better future, winners receiving commendation and prizes of up to JPY200,000 from 180 "Cooperative Partners."

-Applications for "Disruptive Challenge" (support of up to JPY3 million)

The first step, "The 0 to 1 Challenge," features a challenge period of up to 4 months and a support budget of up to JPY1 million. Desired amounts can be set according to how the challenger wishes to light up the path to the goal.

The second step, the "Disruptive Challenge," lets challengers continue on, subtracting the time and budget used in the first step for a challenge period of up to 1 year and a maximum support budget of up to JPY3 million.

-Applications for Generation Award (Receive JPY200,000 for each Category Award)

In cooperation with the Cooperative Partners of this program, Category Award Prizes (JPY200,000) and Special Corporate Awards will be offered. In addition, those proposals nominated for the awards (185 from last year) will be given the opportunity to implement their ideas in cooperation with these partnering companies.

-Creations and Inventions from Prior "INNO-vation Programs"

For videos, interviews, and more about the program, please view the official showcase at InnoUvators: https://innouvators.com/inno/

Register e-mail for information on upcoming INNO-related events at: https://innouvators.com/inno-mail/

-Application Method

Application Period:

From GMT 8:00 am/JST 5:00 pm Wednesday, July 1, 2020, to GMT 9:00 am/JST 6:00 pm Monday, August 31, 2020

Please apply via the application form within the INNO-vation website: https://www.inno.go.jp/en

There are no restrictions on the age, nationality, and residence of applicants.

SOURCE KADOKAWA ASCII Research Laboratories, Inc.


These press releases may also interest you

at 23:16
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

at 23:05
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

at 23:03
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: